Navigation Links
3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Children's Hospitals"
Date:6/26/2012

TUCSON, Ariz., June 26, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named three pediatric centers that offer the SynCardia temporary Total Artificial Heart among the nation's Top 10 "Best Children's Hospitals" for Cardiology and Heart Surgery in its annual list. The Children's Hospital of Philadelphia (CHOP) was ranked #2, Texas Children's Hospital was ranked #3 and Cincinnati Children's Hospital Medical Center was ranked #9.

(Photo: http://photos.prnewswire.com/prnh/20120626/LA30437)

In May 2011, Texas Children's became the first pediatric hospital in the world to implant the Total Artificial Heart. The patient, 17-year-old Jordan Merecka, was born with a "reversed" heart (dextrocardia) and his heart vessels backwards (corrected transposition of the great arteries). In August 2011, he became the first pediatric Total Artificial Heart patient to be discharged from the hospital using the Freedom® portable driver, the world's first wearable power supply for the Total Artificial Heart. Jordan received his heart transplant on Oct. 20, 2011. This August, he will begin his first day of classes in the Maritime Systems Engineering program at Texas A&M.

"One of the most impressive things about the Total Artificial Heart is it can take the most ill patients who are in multi-system organ failure, reverse the process and recuperate these patients for whom other forms of mechanical therapy may fall short," said Dr. David L.S. Morales, Jordan's surgeon and the new chief of pediatric cardiothoracic surgery at Cincinnati Children's. "The Total Artificial Heart has opened the flood gates in respect to the treatment possibilities for a quickly growing population of children in heart failure, including adolescents suffering from chronic rejection of their transplanted heart, end-stage heart failure accompanied by multiple congenital defects and a chronic failed Fontan circulation."

In January 2012, CHOP became the first hospital to implant the Total Artificial Heart into a pediatric patient who was born with only one functional heart ventricle and was suffering from a failed Fontan procedure. The teenager was bridged to a transplant with the Total Artificial Heart in March 2012.

"Pediatric patients who have undergone multiple operations often have no surgical options remaining other than cardiac transplantation," said Dr. J. William Gaynor, an attending cardiothoracic surgeon at CHOP. "When the SynCardia Total Artificial Heart is compared to ventricular assist devices, there is simply no other device which offers the same improvement in cardiac output, the same flexibility for complex congenital heart disease and the same opportunity to improve the condition of these patients and their long-term survival."

In March, Phoenix Children's Hospital bridged its first patient to transplant with the Total Artificial Heart. This marked three consecutive pediatric patients bridged to transplant with the Total Artificial Heart during a six-month period ending March 2012.

The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

CAUTION – The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart… read more


'/>"/>
SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
2. Glytec Adds Pediatric Insulin Dosing to its IV and SubQ FDA Clearances
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
5. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
6. Schulman Associates IRB offers oncology-focused review board
7. MMRGlobal and Fujitsu Offer Low-Cost System to Digitize Medical Records
8. Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
9. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
10. Novelos Therapeutics Prices $5.4 Million Public Offering
11. Bayer Partnership Delivers Industry-First Dose Management Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):